Vatican-backed stem cell research gets $1.2 mln US grant

A Vatican-backed US company that researches an alternative to embryonic stem cells on Friday received a $1.2 million dollar government grant, despite independent studies that question whether their product even exists.

NeoStem, a New Jersey-headquartered company, is investigating very small embryonic-like (VSEL) cells found in adult bone marrow that they say may be able to regrow into different kinds of tissue.

The research has stirred controversy due to NeoStem's marketing partnership with the Vatican and three independent studies that have been unable to confirm the cells are even there.

The latest peer-reviewed grant, totaling $1,221,854, was provided by the US National Institutes of Health for research on an experimental drug that could regenerate damaged by periodontitis, a serious .

The company, along with other partner institutions, has already received $4.5 million in government research grants, including from the Department of Defense and the NIH.

"We are very excited about our progress towards the IND (investigational new drug) submission for what we expect to be the first human clinical study for our VSEL Technology and for the support of the NIH," said a statement by NeoStem chief executive Robin Smith.

The phase two trial could begin later this year or early next, and would be conducted in cooperation with investigators at the University of Michigan, the company said.

In July, scientists at Stanford University said in the journal Stem Cell Reports they could not replicate NeoStem's findings of VSELs in the bone marrow of .

Instead, they found that what was purported to be VSELs—about five micrometers in diameter—were either debris or .

Two previous studies published in the journal PLoS One in 2012 and 2013 also described unsuccessful attempts to locate the cells.

The field of stem cell research has raised hopes of finding cures for everything from blindness to paralysis, but the work is controversial and fraught with legal barriers over patents.

Embryonic has been a political lightning rod, opposed by religious groups and individuals who find fault with destroying a human life form.

Meanwhile, stem cells isolated from adult tissues are receiving plenty of attention, but researchers have yet to find a way to use them on a large scale to safely and efficiently regenerate organs and tissues.

add to favorites email to friend print save as pdf

Related Stories

Tracking nanodiamond-tagged stem cells

Aug 05, 2013

A method that is used to track the fate of a single stem cell within mouse lung tissue is reported in a study published online this week in Nature Nanotechnology. The method may offer insights into the factors that determ ...

Vatican, biotech firm host adult stem cell meeting

Nov 09, 2011

(AP) -- The Vatican has entered into an unusual partnership with a small U.S. biotech company to promote using adult stem cells for treating disease, rather than focusing research on embryonic stem cells.

Recommended for you

User comments